News | May 20, 2025
Crosslay Remedies acquires land adjacent to Max Super Speciality Hospital, Vaishali
CRL shall invest another Rs. 200 crore for creation of additional beds
CRL shall invest another Rs. 200 crore for creation of additional beds
She has held senior positions at Coca-Cola in China and PepsiCo in India
Shilpa Pharma Lifesciences, Unit-1, received EIR from USFDA
The company has posted net profit of Rs. 0.54 crores for the Financial Year ended March 31, 2025
The company has posted net profit of Rs. 260.10 crores for the Financial Year ended March 31, 2025
Jubilant Pharmova has posted net profit of Rs. 839.4 crores for the Financial Year ended March 31, 2025
Shelter Pharma Limited is set to capitalize on the growing demand for natural health products in India
Ideal for extreme dry skin and hyperkeratotic conditions such as psoriasis and ichthyosis, Ureaderm offers the next step in evidence-based, effective skin hydration
_256_384.jpg)
The company reported 30.1% jump in Q4 FY25 PAT at Rs. 1,222 crore
The Board of Directors of the company recommends a final dividend of Rs. 42 per equity share for the 12 months period ended March 31, 2025
Subscribe To Our Newsletter & Stay Updated
